CXCR4 and cancer: Our study demonstrated that the tumor-promoting activity of RUNX2 was attributable to its transcriptional up-regulation of the chemokine receptor CXCR4, which has been shown to mediate the invasion and metastasis of a variety of cancers [33, 34].